Suchen
electroCore, Inc.
ECORZur Watchlist hinzufügen
11.680USD
+0.300+2.64%
Handelsschluss 09-18 16:00（ET）
105.05MMarktkapitalisierung
VerlustKGV TTM
Nachbörsliches Trading 16:14 (ET)11.500USD-0.180-1.54%
Nachbörsliches Trading 16:14 (ET)mehr Informationen über electroCore, Inc. Unternehmen
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.
electroCore, Inc. Profil
BörsenkürzelECOR
Name des UnternehmenselectroCore, Inc.
IPO-datumJun 22, 2018
CEOGoldberger (Daniel S)
Anzahl der mitarbeiter73
WertpapierartOrdinary Share
GeschäftsjahresendeJun 22
Addresse200 Forge Way
StadtROCKAWAY
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07866
Telefon19732900097
Websitehttps://www.electrocore.com/
BörsenkürzelECOR
IPO-datumJun 22, 2018
CEOGoldberger (Daniel S)
Führungskräfte von electroCore, Inc.
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
186.27K
+40.84%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
96.44K
-6.57%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
96.44K
-6.57%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
96.44K
-6.57%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+7.19%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+7.19%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+7.19%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+8.76%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+8.76%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+8.76%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
186.27K
+40.84%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
96.44K
-6.57%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
96.44K
-6.57%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
96.44K
-6.57%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+7.19%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+7.19%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von electroCore, Inc.?
Die fünf größten Anteilseigner von electroCore, Inc. sind: Mr. Daniel S. (Dan) Goldberger
Wie viele Institutionen halten Anteile an electroCore, Inc. (ECOR)?
Mit Stand vom 2026Q1 halten 80 Institutionen Anteile an electroCore, Inc., mit einem Gesamtmarktwert von etwa 923.46K, was 11.44% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -331677.00 gestiegen.
Was ist die größte Einnahmequelle von electroCore, Inc.?
Am 2026Q1 erzielte das Geschäft mit United States Rx für electroCore, Inc. den höchsten Umsatz in Höhe von 7.45M, was 78.80% des Gesamtumsatzes entspricht.